Premelle LD-0,3/1,5 Namībija - angļu - Namibia Medicines Regulatory Council

premelle ld-0,3/1,5

pfizer laboratories (pty) ltd - conjugated oestrogen, medroxyprogesterone acetate - tablets - each tablet contains conjugated oestrogen 0,3 mg, medroxyprogesterone acetate 1,5 mg

Premelle LD-0,45/1,5 Namībija - angļu - Namibia Medicines Regulatory Council

premelle ld-0,45/1,5

pfizer laboratories (pty) ltd - conjugated oestrogen, medroxyprogesterone acetate - tablets - each tablet contains conjugated oestrogen 0,45 mg, medroxyprogesterone acetate 1,5 mg

Premelle 2.5mg Namībija - angļu - Namibia Medicines Regulatory Council

premelle 2.5mg

pfizer laboratories (pty) ltd - conjugated estrogens medroxyprogesterone acetate - tablets - each tablet contains conjugated estrogens 0.625mg and medroxyprogesterone acetate 2.5mg

Premelle 5mg Namībija - angļu - Namibia Medicines Regulatory Council

premelle 5mg

pfizer laboratories (pty) ltd - conjugated estrogens medroxyprogesterone acetate - tablets - each tablet contains conjugated estrogens 0.625mg and medroxyprogesterone acetate 5mg

IMJUDO CONCENTRATE FOR SOLUTION FOR INFUSION 20MGML Singapūra - angļu - HSA (Health Sciences Authority)

imjudo concentrate for solution for infusion 20mgml

astrazeneca singapore pte ltd - tremelimumab - infusion, solution concentrate - tremelimumab 20 mg/ml

Imjudo 300 mg/15 mL (20 mg/mL) Concentrate for Solution for Infusion (IV) Filipīnas - angļu - FDA (Food And Drug Administration)

imjudo 300 mg/15 ml (20 mg/ml) concentrate for solution for infusion (iv)

astrazeneca ab; importer: astrazeneca pharmaceuticals (phils.), inc.; distributor: astrazeneca pharmaceuticals (phils.), inc. - tremelimumab - concentrate for solution for infusion (iv) - 300 mg/15 ml (20 mg/ml)

Imjudo 25 mg/1.25 mL (20 mg/mL) Concentrate for Solution for Infusion (IV) Filipīnas - angļu - FDA (Food And Drug Administration)

imjudo 25 mg/1.25 ml (20 mg/ml) concentrate for solution for infusion (iv)

astrazeneca ab; importer: astrazeneca pharmaceuticals (phils.), inc.; distributor: astrazeneca pharmaceuticals (phils.), inc. - tremelimumab - concentrate for solution for infusion (iv) - 25 mg/1.25 ml (20 mg/ml)

IMJUDO Injection 25mg (イジュド点滴静注25mg) Japāna - angļu - すりの適正使用協議会 RAD-AR Council, Japan

imjudo injection 25mg (イジュド点滴静注25mg)

astrazeneca k.k - tremelimumab (genetical recombination) - injection

IMJUDO Injection 300mg (イジュド点滴静注300mg) Japāna - angļu - すりの適正使用協議会 RAD-AR Council, Japan

imjudo injection 300mg (イジュド点滴静注300mg)

astrazeneca k.k - tremelimumab (genetical recombination) - injection

MAYFAIRER Malaizija - angļu - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

mayfairer

sterling bloom (m) sdn bhd - tremella fusiformis berk (fungus); spica ptunella vulgaris; radix trichosanthes kirilowii; radix panax quinquefolii; radix glehniae littoralis; pearl powder; massa medicata fermentata; flos sophora japonica; flos lonicera japonica; radix gentiana scabra; herba leonurus heterophyclus -